Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: The multi-ethnic study of atherosclerosis and the heinz nixdorf recall study

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 310-316

  Delaney, Joseph A ^a,b   Lehmann, Nils ^c   Jöckel, Karl Heinz ^c   Elmariah, Sammy ^d   Psaty, Bruce M ^e,f   Mahabadi, Amir A ^g   Budoff, Matt ^h   Kronmal, Richard A ^b   Nasir, Khurram ⁱ   O'Brien, Kevin D ^b   Möhlenkamp, Stefan ^g   Moebus, Susanne ^c   Dragano, Nico ^j   Winterstein, Almut G ^a   Erbel, Raimund ^g   Kälsch, Hagen ^g  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f CENTER FOR HEALTH STUDIES   (United States)

^g UNIVERSITY HOSPITAL ESSEN   (Germany)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ JOHNS HOPKINS HOSPITAL   (United States)

^j HEINRICH HEINE UNIVERSITY   (Germany)

more..

Author keywords

Aortic valve calcification; Aspirin; Coronary artery calcification; Heinz Nixdorf Recall Study; Multi Ethnic Study of Atherosclerosis; Non steroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; GLUCOSE; LIPID; ROFECOXIB; VALDECOXIB;

ADULT; AGED; AORTA VALVE; AORTIC VALVE CALCIFICATION; ARTICLE; BLOOD PRESSURE; BODY MASS; CALCIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; EDUCATIONAL STATUS; ETHNICITY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH INSURANCE; HUMAN; INCIDENCE; INCOME; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SMOKING;

AORTIC VALVE CALCIFICATION; ASPIRIN; CORONARY ARTERY CALCIFICATION; HEINZ NIXDORF RECALL STUDY; MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AORTIC VALVE STENOSIS; ASPIRIN; CALCINOSIS; COHORT STUDIES; CORONARY ARTERY DISEASE; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880417271     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.05.002     Document Type: Article

References (30)

1. Wolff T., Miller T., Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 150(6):405-410.
2. De Berardis G., Sacco M., Strippoli G.F., et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. Br Med J 2009, 339:b4531.
3. Younis N., Williams S., Ammori B., Soran H. Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis. Expert Opin Pharmacother 2010, 11(9):1459-1466.
4. Kronmal R.A., Barzilay J.I., Smith N.L., et al. Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001. PLoS Med 2006, 3(10):e400.
5. Grønholdt M.L., Nordestgaard B.G., Bentzon J., et al. Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels. JVasc Surg 2002, 35(1):137-145.
6. Mazzone A., Venneri L., Berti S. Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links. JCardiovasc Med (Hagerstown) 2007, 8(12):983-989.
7. Antman E.M., Bennett J.S., Daugherty A., Furberg C., Roberts H., Taubert K.A. Use of nonsteroidal anti-inflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007, 115:1634-1642.
8. Maréchal C., Coche E., Goffin E., et al. Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients. Am J Kidney Dis 2012, 59(2):258-269.
9. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002, 156(9):871-881.
10. Psaty B.M., Lee M., Savage P.J., Rutan G.H., German P.S., Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. JClin Epidemiol 1992, 45(6):683-692.
11. Smith N.L., Psaty B.M., Heckbert S.R., Tracy R.P., Cornell E.S. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. JClin Epidemiol 1999, 52:143-146.
12. Bertoni A.G., Chung H., Whitt-Glover M., et al. The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Epidemiol 2009, 169(4):444-454.
13. Nettleton J.A., Schulze M.B., Jiang R., Jenny N.S., Burke G.L., Jacobs D.R. Apriori-defined dietary patterns and markers of cardiovascular disease risk in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2008, 88(1):185-194.
14. Erbel R., Möhlenkamp S., Moebus S., et al. Heinz Nixdorf Recall Study Investigative Group. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. JAm Coll Cardiol 2010, 56:1397-1406.
15. Schmermund A., Möhlenkamp S., Stang A., et al. Heinz Nixdorf Recall Study Investigative Group. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf Recall study. Am Heart J 2002, 144:212-218.
16. Schmermund A., Lehmann N., Bielak L.F., et al. Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America. Atherosclerosis 2007, 195(1):e207-e216.
17. Erbel R., Delaney J.A.C., Lehmann N., et al. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the multi-ethnic study of atherosclerosis (MESA) and the Heinz Nixdorf Recall (HNR) study. Eur Heart J 2008, 29(22):2782-2791.
18. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. JAm Coll Cardiol 1990, 15:827-832.
19. Budoff M.J., Takasu J., Katz R., et al. Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. Acad Radiol 2006, 13:166-172.
20. Detrano R.C., Anderson M., Nelson J., et al. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility-MESA study. Radiology 2005, 236:477-484.
21. Delaney J.A.C., Biggs M.L., Kronmal R.A., Psaty B.M. Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis. Pharmacoepidemiol Drug Saf 2011, 20(1):83-89.
22. Zou G. Amodified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004, 159:702-706.
23. Murphy E.J. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 2005, 33(3):311-322.
24. Trelle S., Reichenbach S., Wandel S., et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. Br Med J 2011, 342:c7086.
25. Patrono C., Rocca B. Aspirin: promise and resistance in the new millennium. Arterioscler Thromb Vasc Biol 2008 Mar, 28(3):s25-s32.
26. Stein B., Fuster V., Israel D.H., et al. Platelet inhibitor agents in cardiovascular disease: an update. JAm Coll Cardiol 1989, 14(4):813-836.
27. Ray W.A. Observational studies of drugs and mortality. NEngl J Med 2005, 353(22):2319-2321.
28. Psaty B.M., Koepsell T.D., Lin D., et al. Assessment and control for confounding by indication in observational studies. JAm Geriatr Soc 1999, 47(6):749-754.
29. Brookhart M.A., Patrick A.R., Dormuth C., et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007, 166(3):348-354.
30. Blaha M.J., Budoff M.J., Rivera J.J., et al. Relation of aortic valve calcium detected by cardiac computed tomography to all-cause mortality. Am J Cardiol 2010, 106(12):1787-1791.